2m 2m 2m 2m 2m 2m 2m
Oncotelic Therap (OTLC)
OTC
$0.02-$0.0003 (-1.41%)
Price as of Oct 02, 2026- $14.4MMarket Cap
- -72.00%1-Year Change
- BiotechnologyIndustry
Oncotelic Therap (OTLC)
$0.02-$0.0003 (-1.41%)
OTLC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.02 | ||
Change | -$0.0003 (-1.41%) | ||
Open | $0.03 | ||
High | $0.03 | ||
Low | $0.02 | ||
Previous Close | $0.02 | ||
Volume | 274,748 | ||
30-Day Average Volume | 381,555 | ||
1-Week Change | -17.00% | ||
1-Month Change | -40.68% | ||
1-Year Change | -72.00% | ||
3-Year Change | -27.08% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 399.2M | ||
Total Assets | $30.1M | ||
Market Cap | $14.4M | ||
Enterprise Value | $27.2M | ||
Period: QTR TTM FY | |||
Revenue | $70,000.00 | ||
Net Income | $115,309.00 | ||
Free Cash Flow | -$248,850.00 | ||
EBIT | $300,733.00 | ||
EBITDA | $300,733.00 | ||
Net Working Capital | -$16.7M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 91 | ||
Enterprise Value/Revenue | 389 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -58 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||